https://www.selleckchem.com/pr....oducts/Ilginatinib-h
The shift in the diagnostic algorithm for prostate cancer to early imaging with mpMRI has resulted in many patients being diagnosed with small volume, apparently unilateral, clinically significant cancers. In these patients, a minimally invasive, nonmorbid intervention is appealing. The aim of this study was to review data reported within the last 2 years on focal therapy and partial gland ablation for organ-confined prostate cancer. High-intensity focal ultrasound, focal cryotherapy, photodynamic therapy, irreversible